Schonfeld Strategic Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
+17,926
| New | +$1.49M | 0.01% | 1052 |
|
|
2025
Q1 | – | Sell |
-7,155
| Closed | -$644K | – | 2366 |
|
|
2024
Q4 | $644K | Buy |
7,155
+7,154
| +715,400% | +$644K | ﹤0.01% | 1241 |
|
|
2024
Q3 | $98 | Sell |
1
-173,874
| -100% | -$17M | ﹤0.01% | 1835 |
|
|
2024
Q2 | $16.1M | Sell |
173,875
-1,074
| -0.6% | -$99.6K | 0.1% | 193 |
|
|
2024
Q1 | $16.6M | Sell |
174,949
-51,044
| -23% | -$4.84M | 0.11% | 198 |
|
|
2023
Q4 | $20.2M | Sell |
225,993
-131,797
| -37% | -$11.8M | 0.13% | 138 |
|
|
2023
Q3 | $26.1M | Sell |
357,790
-14,959
| -4% | -$1.09M | 0.2% | 116 |
|
|
2023
Q2 | $31M | Buy |
372,749
+66,943
| +22% | +$5.57M | 0.27% | 96 |
|
|
2023
Q1 | $23.3M | Buy |
305,806
+16,510
| +6% | +$1.26M | 0.22% | 126 |
|
|
2022
Q4 | $24M | Buy |
289,296
+13,458
| +5% | +$1.12M | 0.2% | 134 |
|
|
2022
Q3 | $21.9M | Buy |
275,838
+232,450
| +536% | +$18.4M | 0.18% | 142 |
|
|
2022
Q2 | $3.22M | Sell |
43,388
-12,300
| -22% | -$913K | 0.03% | 551 |
|
|
2022
Q1 | $5.01M | Buy |
55,688
+45,989
| +474% | +$4.13M | 0.05% | 413 |
|
|
2021
Q4 | $1.09M | Buy |
9,699
+8,602
| +784% | +$963K | 0.01% | 833 |
|
|
2021
Q3 | $138K | Buy |
+1,097
| New | +$138K | ﹤0.01% | 1785 |
|
|
2021
Q2 | – | Sell |
-27,366
| Closed | -$3.71M | – | 2298 |
|
|
2021
Q1 | $3.71M | Buy |
+27,366
| New | +$3.71M | 0.05% | 484 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | – | – | 1857 |
|
|
2020
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 1652 |
|